A list of candidate cancer biomarkers for targeted proteomics.
about
M89V Sialic acid Acetyl Esterase (SIAE) and all other non-synonymous common variants of this gene are catalytically normalAdvances in targeted proteomics and applications to biomedical researchThe effect of pre-analytical variability on the measurement of MRM-MS-based mid- to high-abundance plasma protein biomarkers and a panel of cytokinesOptimization of plasma sample pretreatment for quantitative analysis using iTRAQ labeling and LC-MALDI-TOF/TOFProteomic Signatures of ThymomasComprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkersEvaluating the effects of preanalytical variables on the stability of the human plasma proteomeQuantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.Discovery and Validation of Predictive Biomarkers of Survival for Non-small Cell Lung Cancer Patients Undergoing Radical Radiotherapy: Two Proteins With Predictive Value.QC metrics from CPTAC raw LC-MS/MS data interpreted through multivariate statisticsGlobal Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia PatientsA Comparison of the Proteomic Expression in Pooled Saliva Specimens from Individuals Diagnosed with Ductal Carcinoma of the Breast with and without Lymph Node InvolvementReconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: an NCI-CPTC initiative perspective.Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studiesFast proteomic protocol for biomarker fingerprinting in cancerous cells.Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas.Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics.Towards proteome standards: the use of absolute quantitation in high-throughput biomarker discovery.A blood-based proteomic classifier for the molecular characterization of pulmonary nodules.Impact of protein stability, cellular localization, and abundance on proteomic detection of tumor-derived proteins in plasma.A pilot study to evaluate the application of a generic protein standard panel for quality control of biomarker detection technologies.Comparative proteomic approach identifies PKM2 and cofilin-1 as potential diagnostic, prognostic and therapeutic targets for pulmonary adenocarcinomaPlasma proteome response to severe burn injury revealed by 18O-labeled "universal" reference-based quantitative proteomicsCombining ultracentrifugation and peptide termini group-specific immunoprecipitation for multiplex plasma protein analysis.Proteomic study reveals a functional network of cancer markers in the G1-Stage of the breast cancer cell cycleA minimal connected network of transcription factors regulated in human tumors and its application to the quest for universal cancer biomarkersReproducible quantification of cancer-associated proteins in body fluids using targeted proteomics.Mass spectrometry based glycoproteomics--from a proteomics perspectiveIntegrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancerEnhanced sensitivity for selected reaction monitoring mass spectrometry-based targeted proteomics using a dual stage electrodynamic ion funnel interface.Restructuring proteomics through verificationN-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications.Multiplexed homogeneous proximity ligation assays for high-throughput protein biomarker research in serological material.Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry.Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.Secretome-based identification of ULBP2 as a novel serum marker for pancreatic cancer detection.A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlasDifferential carbonylation of proteins as a function of in vivo oxidative stress.A peptide N-terminal protection strategy for comprehensive glycoproteome analysis using hydrazide chemistry based method.Ion-permeable membrane for on-chip preconcentration and separation of cancer marker proteins
P2860
Q24308044-19C8FD3B-C037-4980-915B-8E4224654A79Q28066912-E657F849-80B5-4530-A8BC-F9E2BBB43B3CQ28484137-ABB16F28-A612-49D5-A6AF-BB67C857453AQ28540277-92B33B07-F207-4965-9498-4B0CDB3BEF0AQ28553440-A163A693-F9C7-49F1-8522-188A623F3F91Q28741004-E7DD8D6E-3863-4106-9C4E-FE1F50D1732AQ30372676-0E6BB56E-D895-4C1C-BEE2-D8D87F41B82BQ30576595-1F292442-369D-4F71-899A-F1E842DB3C27Q30664020-E49A22CE-C4B6-4BF4-864E-8D3EA94681BDQ30747888-9478E9D3-08B5-4969-BDE5-6284CDCDF236Q33555287-D1399CE3-FEA1-46A0-B251-B6A10466037BQ33568539-118A7A77-F9C8-4DB0-9C2F-B3183CCE74BFQ33669587-E101E018-6A10-4EAE-A181-3EF85DD500F3Q33688759-2DA9EC08-7559-4616-978F-72A3FF05E853Q33798196-33751175-A7AA-4F68-9525-AFD9560B1E9CQ33883005-D932C440-806D-495A-BEB7-8BCC97112F09Q33888970-D85CF07F-0A34-4C37-AD73-D31C303DEAAFQ33912503-4088D068-AF33-4DDD-A90E-E67F86196B11Q33968948-D83A3E6C-9894-41B5-98D4-D27245852534Q33988224-969B7087-D3C8-4BD4-A7B1-4A3ED69115A6Q33990932-CCE06352-3F09-4202-BFE4-8AE2F3A37A0FQ34075588-ACA8CD09-F695-4E75-9256-C73F9CB82B3CQ34154148-D33E2ED2-44E2-4EDA-82D9-560B04DA181AQ34242987-DE1A8F57-B216-46D8-A2C6-DF1B2B671A9CQ34278751-296D2183-ECC6-4B30-AC41-4AD99D6E394AQ34326409-83C69AE6-60F3-4BCC-BB09-13015A1D2973Q34333925-DA8346F3-50D8-48BE-B6B9-A14EBAD23230Q34454989-F7A799F7-8392-42F6-B6FE-470984A3DEF3Q34532251-4E08672A-F8C7-4BDB-AD04-C6647C4210DBQ34551781-C89F3E73-E64B-4708-AD43-0EC9DA58B142Q34585479-455C94F5-7DBB-4BE9-A151-CEFE75A9B4B1Q34585592-6F90F644-ACC1-48DE-AC51-34E0EA878117Q34751658-B15B1B2C-8289-4DC5-903B-E6C7283B944EQ34751690-7ED2F89D-4BE5-48C9-9F03-7884C2E90257Q34958895-117445B1-7972-4AF5-98A1-D6D3F0F77B19Q34995279-FAA5927E-95C4-4E78-A04B-B012C0107266Q35264564-D986AA2B-207F-4940-B323-672C45019CD1Q35384877-9A073B6F-88B7-42F1-AD28-8D60D606BB41Q35591012-BFE65C1C-229A-46A3-9298-A513DBCFCDD5Q35622975-A3832B04-65BC-4EE3-8E01-5D212B88205F
P2860
A list of candidate cancer biomarkers for targeted proteomics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 February 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A list of candidate cancer biomarkers for targeted proteomics.
@en
A list of candidate cancer biomarkers for targeted proteomics.
@nl
type
label
A list of candidate cancer biomarkers for targeted proteomics.
@en
A list of candidate cancer biomarkers for targeted proteomics.
@nl
prefLabel
A list of candidate cancer biomarkers for targeted proteomics.
@en
A list of candidate cancer biomarkers for targeted proteomics.
@nl
P2860
P1433
P1476
A list of candidate cancer biomarkers for targeted proteomics.
@en
P2093
Malu Polanski
N Leigh Anderson
P2860
P577
2007-02-07T00:00:00Z